Humana ditches profit goal amid 'unprecedented' surge in medical costs
The company also abandoned the long-term profit target it had pledged to reach in 2025.
As featured on
Humana Inc., Kentucky's largest publicly traded company, presented a grim outlook for investors on Thursday, saying an "unprecedented" surge in medical costs near the end of 2023 will continue throughout 2024.
